/

Investors / United States / Kairos Ventures

Kairos Ventures

Venture capital · Beverly Hills, CA, United States · North America

kairosventures.com

Kairos Ventures invests in, supports and commercializes scientific discoveries from top universities and scientists, turning them into businesses. It makes early-stage investments of $150,000 to $20 million and provides portfolio services in legal, finance, marketing, operations, business development and HR.

Invests inHealthcare & BiotechAI & Machine Learning

In its own wordssciencedeep techuniversity spinoutscommercializationearly stage

Your fit with Kairos Ventures

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
23portfolio companies
1funding rounds on record
1rounds, last 12 months
$5M to $20Mtypical round it comes in at
Series Amost frequent entry

Kairos Ventures lists 23 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (41%), AI & Machine Learning (34%) and Fintech (9%). 63% of its companies are based in United States. It invests most often alongside 360 Capital, Alecla7 and Alter Global.

Counts come from funding rounds that name Kairos Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.

Round figures show recent activity, not Kairos Ventures' whole history. Rounds on record name 1 company; its own site lists 23. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.

Entry stage

share of companies by the stage of its first round
Show as a table
Share of companies by the stage of the firm's first round
Value
Pre-seed0%
Seed0%
Series A100%
Series B0%
Growth0%

Activity by year

rounds it joined, last 10 years
Show as a table
Funding rounds per year
TotalRounds it led
'1700
'1800
'1900
'2000
'2100
'2200
'2300
'2400
'2500
'2610

Investor profile

percentile among all firms
Portfolio size: 23 companiesRecent activity: 1 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 41% in its largest sectorReach: 6 countriesPortfolio size57th pctRecent activity59th pctEarly stage54th pctEvidence52th pctSector focus74th pctReach84th pct
This firmMedian of all firms
Show as a table
Kairos Ventures compared with all firms
MeasurePercentile of all firmsValue
Portfolio size57th23 companies
Recent activity59th1 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus74th41% in its largest sector
Reach84th6 countries

Invests most often with

firms sharing its portfolio companies
Show as a table
Co-investors
Share
360 Capital1
Alecla71
Alter Global1
BioStar Capital1
Bison Ventures1
Bold Capital Partners1
CDP Venture Capital1
Capitoria1

All co-investors

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers23100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech41%15%
AI & Machine Learning34%18%
Fintech9%12%
Industrial & Manufacturing6%7%
Human Resources3%1%
E-commerce & Marketplaces3%6%
Cybersecurity3%4%

Compare Kairos Ventures head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Recent portfolio activity

when companies last raised with Kairos Ventures
DateCompanyStage
21 Sept 2026Tundrtundr.techSeries A

Round details for Kairos Ventures

Amounts, full round histories and every co-investor in Kairos Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.

See rounds on Fundup AI →

Portfolio

23 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Actiniaactiniadetectors.comActinia develops cutting-edge radiation detector materials to improve radiological imaging techniques
Healthcare & Biotech
Portfolio page
Actuate Therapeuticsactuatetherapeutics.com · United StatesActuate Therapeutics develops novel therapies, including its lead drug elraglusib, to treat hard-to-treat cancers
Healthcare & Biotech
Portfolio page
Amorphologyamorphology.comAmorphology manufactures high-precision metallic components using amorphous metals and Bulk Metallic Glasses (BMG's)
Industrial & ManufacturingAI & Machine Learning
Portfolio page
Avvio Medicalavviomedical.com · United StatesAvvio Medical is transforming the standard of care for urinary stone disease with a cutting-edge, outpatient procedure that reduces wait times and eliminates the need for routine stents or general anesthesia.
Healthcare & Biotech
Portfolio page
Behavioral Signalsbehavioralsignals.comBehavioral Signals provides speech emotion and deepfake detection services through an API
AI & Machine LearningCybersecurity
Portfolio page
Chimera Bioengineeringchimera.bio · United StatesChimera Bioengineering creates treatments centered around controlling cancer at the cell level using CAR-T Cell Therapy
Healthcare & Biotech
Portfolio page
Clearsenseclearsense.com · United StatesClearsense provides a healthcare data platform that integrates and manages data from disparate sources
Healthcare & Biotech
Portfolio page
CytoDelcytodel.com · United StatesCytoDel is a preclinical stage biopharmaceutical company developing recombinant botulinum toxin derivatives that can deliver therapeutics to the neuronal cytoplasm
Healthcare & Biotech
Portfolio page
DEARhealthdearhealth.com · NetherlandsDEARhealth develops software as a medical device using dynamic and risk-based care pathways and smart decision support recommendations
Healthcare & Biotech
Portfolio page
Foldaxfoldax.com · United StatesFoldax develops and manufactures heart valve technology, including the TRIA Mitral Valve
Healthcare & Biotech
Portfolio page
Guruguru.com.vc · BrazilGuru is a company that provides an app for investing in stocks and other financial assets
Fintech
Portfolio page
Holoclaraholoclara.comHoloclara develops novel therapeutics derived from symbiotic organisms that modulate inflammation, metabolism, and tissue regeneration
Healthcare & Biotech
Portfolio page
Mattiqmattiq.comMattiq generates experimental materials data for AI and discovery
AI & Machine LearningIndustrial & Manufacturing
Portfolio page
MemVergememverge.com · United StatesMemVerge develops AI tools and products that focus on user memory and preferences
AI & Machine Learning
Portfolio page
Neuro-Bioneuro-bio.comNeuro-Bio is a biotech company that develops diagnostic and therapeutic strategies for neurodegenerative diseases
Healthcare & Biotech
Portfolio page
Pomelopomelo.la · ArgentinaPomelo provides technology for card businesses, including payment infrastructure and card management platforms.
FintechE-commerce & Marketplaces
Portfolio page
Proviviprovivi.com · USAProvivi has a catalog and provides something to farmers and has science involved
AI & Machine LearningAI & Machine Learning
Portfolio page
PteroDynamicspterodynamics.comPteroDynamics designs superior autonomous VTOL aircraft that fly faster and go farther to reach remote locations without runways, even in harsh conditions.
AI & Machine LearningAI & Machine Learning
Portfolio page
Quicksilver Biosciencesquicksilverbiosciences.com · United StatesQuicksilver Biosciences is developing a versatile CMOS-integrated biosensor platform.
Healthcare & Biotech
Portfolio page
Specter Aerospacespecteraerospace.com · United StatesSpecter Aerospace is building hypersonic vehicles that will deter future conflicts and connect the world like never before.
AI & Machine LearningAI & Machine Learning
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of Kairos Ventures, as last read
kairosventures.com as VCinfo last read it
Site
kairosventures.com
Last read
5 Nov 2026
Watching since
5 Nov 2026
Rounds since
21 Sept 2026
Companies checked
23

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Kairos Ventures' profile as data

Pull Kairos Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/kairosventures.com

# also
GET /v1/firms/kairosventures.com/portfolio
GET /v1/firms/kairosventures.com/coinvestors
GET /v1/firms/kairosventures.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing